semaglutide cardiovascular trial SELECT Beyond obesity: Novo's SELECT re-defines

Injection Anxiety or Administration Difficulties Self-injecting weekly is not trivial, and for some patients the psychological barrier is simply too significant to overcome

Horsham warns

If you are also taking an SGLT2 inhibitor (such as dapagliflozin, empagliflozin, or canagliflozin), be aware that these medications are known to increase the risk of genital yeast infections

Wegovy is a higher dosage version of the diabetes drug Ozempic

Altered lipid metabolism characterised by the reprogramming of de novo fatty acid biosynthesis and augmented b-oxidation, driven by increased expression of FASN and enhanced mitochondrial activity, is a common event in the development and progression of cancer [281]